Department of Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH 44195, USA.
Cleve Clin J Med. 2013 Feb;80(2):117-25. doi: 10.3949/ccjm.80a.11094.
The latest recommendations for preventing and treating glucocorticoid-induced osteoporosis, published by the American College of Rheumatology (ACR) in 2010, incorporate developments that occurred since the release of its 2001 guidelines, such as new drugs and the World Health Organization's Fracture Risk Assessment Tool, or FRAX. They outline a more targeted approach but have the possible disadvantage of being more complicated and therefore harder to use.
美国风湿病学会(ACR)于 2010 年发布的预防和治疗糖皮质激素性骨质疏松症的最新建议,纳入了自 2001 年指南发布以来的新进展,如新药和世界卫生组织骨折风险评估工具(FRAX)。这些建议概述了一种更具针对性的方法,但可能存在更复杂且更难使用的缺点。